(Q40926531)

24 September 2017

title

p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma (English)

1 reference

24 September 2017

Safran H

1

1 reference

24 September 2017

King T

2

1 reference

24 September 2017

Choy H

3

1 reference

24 September 2017

Gollerkeri A

4

1 reference

24 September 2017

Kwakwa H

5

1 reference

24 September 2017

Lopez F

6

1 reference

24 September 2017

Cole B

7

1 reference

24 September 2017

Myers J

8

1 reference

24 September 2017

Tarpey J

9

1 reference

24 September 2017

Rosmarin A

10

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

24 September 2017

1 reference

24 September 2017

volume

78

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

1203-1210

1 reference

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Promotion of microtubule assembly in vitro by taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Taxol binds to polymerized tubulin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Investigation of taxol as a potential radiation sensitizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Implications of the p53 tumor-suppressor gene in clinical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Apoptosis. Its significance in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

p53 is required for radiation-induced apoptosis in mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Thymocyte apoptosis induced by p53-dependent and independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

p53: a frequent target for genetic abnormalities in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Increased expression of mutant forms of p53 oncogene in primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Phase I study of taxol using a 5-day intermittent schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

In vitro studies of Taxol as a radiation sensitizer in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

p53 status and the efficacy of cancer therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

p53: from molecular mechanisms to prognosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960915%2978%3A6%3C1203%3A%3AAID-CNCR6%3E3.0.CO%3B2-A

10.1002/(SICI)1097-0142(19960915)78:6<1203::AID-CNCR6>3.0.CO;2-A

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference